Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-12
DOI
10.1038/s41388-018-0333-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of potential therapeutic targets in prostate cancer through a cross‐species approach
- (2018) Sarah Jurmeister et al. EMBO Molecular Medicine
- Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer
- (2018) Kosei Hasegawa et al. JOURNAL OF IMMUNOTHERAPY
- MELK expression correlates with tumor mitotic activity but is not required for cancer growth
- (2018) Christopher J Giuliano et al. eLife
- MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells
- (2017) Reto S. Kohler et al. GYNECOLOGIC ONCOLOGY
- Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma
- (2017) Arnold Bolomsky et al. HAEMATOLOGICA
- Deciphering Ibrutinib Resistance in Chronic Lymphocytic Leukemia
- (2017) Georg Lenz JOURNAL OF CLINICAL ONCOLOGY
- Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma
- (2017) Xiangxiang Zhou et al. Journal of Hematology & Oncology
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
- (2017) Radoslav Janostiak et al. Cell Reports
- MELK is not necessary for the proliferation of basal-like breast cancer cells
- (2017) Hai-Tsang Huang et al. eLife
- Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma
- (2017) Arnold Bolomsky et al. HAEMATOLOGICA
- Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia
- (2017) Alessandra Trojani et al. Cancer Biomarkers
- FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway
- (2016) Ke Wang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma
- (2016) KIYOKAZU HIWATASHI et al. ANTICANCER RESEARCH
- MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence
- (2016) Hongping Xia et al. CANCER LETTERS
- Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer
- (2016) C. Speers et al. CLINICAL CANCER RESEARCH
- Oncogenic Actions of SKP2 Involves Deregulation of CDK1 Turnover Mediated by FOXM1
- (2016) Anand Krishnan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Ibrutinib holds promise for patients with 17p deletion CLL
- (2016) Paolo Ghia LANCET ONCOLOGY
- Nuclear FOXM1 drives chemoresistance in AML
- (2016) I Khan et al. LEUKEMIA
- HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes
- (2016) J Cui et al. ONCOGENE
- Prognostic factors and risk stratification in chronic lymphocytic leukemia
- (2016) Sameer A. Parikh et al. SEMINARS IN ONCOLOGY
- The Forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells
- (2016) C.T.D. Kwok et al. Stem Cell Research
- Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
- (2016) A T Stefka et al. Blood Cancer Journal
- MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
- (2015) L. Beke et al. BIOSCIENCE REPORTS
- The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6
- (2015) Kang Lu et al. CANCER LETTERS
- The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
- (2015) A. Wiestner HAEMATOLOGICA
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
- (2015) P Khongkow et al. ONCOGENE
- The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
- (2015) A. Wiestner HAEMATOLOGICA
- EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner
- (2015) Sung-Hak Kim et al. Stem Cell Reports
- Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
- (2015) Suyoun Chung et al. Oncotarget
- Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
- (2015) Houda Alachkar et al. Oncotarget
- miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1
- (2014) M. Mraz et al. BLOOD
- SnapShot: Chronic Lymphocytic Leukemia
- (2014) Maria Ciccone et al. CANCER CELL
- PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model
- (2014) T Motiwala et al. LEUKEMIA
- Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL)
- (2014) N. L. Komarova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOX(M1) News--It Is Cancer
- (2013) M. Halasi et al. MOLECULAR CANCER THERAPEUTICS
- MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
- (2013) Kaushal Joshi et al. STEM CELLS
- Tumor-Specific Activation of the C-JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53-Dependent Manner
- (2013) Chunyu Gu et al. STEM CELLS
- Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression
- (2012) H.-Y. Chuang et al. BLOOD
- Therapeutic advancement of chronic lymphocytic leukemia
- (2012) Kang Lu et al. Journal of Hematology & Oncology
- High expression ofMZB1predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature
- (2012) Tobias Herold et al. LEUKEMIA & LYMPHOMA
- Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression
- (2011) Seungho Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia
- (2011) T Herold et al. LEUKEMIA
- Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
- (2010) Torsten Haferlach et al. JOURNAL OF CLINICAL ONCOLOGY
- Spliced Leader Trapping Reveals Widespread Alternative Splicing Patterns in the Highly Dynamic Transcriptome of Trypanosoma brucei
- (2010) Daniel Nilsson et al. PLoS Pathogens
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
- (2008) Alexander Kohlmann et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started